Trials / Unknown
UnknownNCT00219869
Galantamine in the Treatment of Post-Traumatic Headache
Galantamine in the Preventive Treatment of Chronic Post-Traumatic Headache
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (planned)
- Sponsor
- Rapoport, Alan, M.D. · Individual
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
Most patients with CPTH present with additional major cognitive, behavioral and somatic problems. Most drugs used currently have a negative influence on cognition. Therefore, treatment strategies addressing both the headache and cognitive disturbances in patients with CPTH are necessary. (CPTH; Chronic Post Traumatic Headache).
Detailed description
Headache is the most common symptom after a closed head injury, persisting for more then 2 months in 60% of the patients. CPTH is an important cause of consultations in neurology offices and headache clinics, posing a severe burden and affecting the quality of life of sufferers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Galantamine |
Timeline
- Start date
- 2005-07-01
- Completion
- 2005-08-01
- First posted
- 2005-09-22
- Last updated
- 2005-09-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00219869. Inclusion in this directory is not an endorsement.